基于关联规则和复杂系统熵聚类的HBeAg阳性慢性乙型肝炎用药规律分析

焦云涛; 李小科; 杨先照; 叶永安

doi:10.3969/j.issn.1001-5256.2016.11.012

基于关联规则和复杂系统熵聚类的HBeAg阳性慢性乙型肝炎用药规律分析

DOI: 10.3969/j.issn.1001-5256.2016.11.012

北京中医药大学东直门医院

基金项目:

国家“十一五”重大传染病防治专项课题(2008ZX10005006)；

详细信息

中图分类号: R512.62
计量
- 文章访问数: 1744
- HTML全文浏览量: 32
- PDF下载量: 434
- 被引次数: 0
出版历程
- 出版日期: 2016-11-20

An analysis of medication rule for HBeAg-positive chronic hepatitis B based on association rule and complex system entropy clustering

Research funding:

摘要

摘要: 目的探讨HBe Ag阳性慢性乙型肝炎(CHB)的中医用药特点和组方规律。方法检索中国知网、万方数据资源库和维普期刊资源整合服务平台中HBe Ag阳性CHB的中医证治文献,提取医案的中医诊治信息,经过数据标准化处理并建立数据库,运用中医传承辅助系统挖掘其用药规律。结果共纳入文献100篇,医案135例。共使用220种中药,其中用药频数较高的中药为柴胡、丹参、甘草、白术、茯苓等;在药物归经中频数较高的为肝经、脾经、胃经等。分析出治疗HBe Ag阳性CHB的核心药物为柴胡、白术、白芍、郁金、丹参、甘草、茯苓、虎杖、黄芪、茵陈、白花蛇舌草;基于复杂系统熵聚类,推演出药物核心组合20个;并在此基础上,运用无监督熵层次聚类算法,得到新处方10个。结论通过文献挖掘及归纳分析,提示肝郁脾虚证、肝胆湿热证是HBe Ag阳性CHB常见证型,总结出了核心药对和新处方,以供临床借鉴。
- 肝炎,乙型,慢性 /
- 肝炎核心抗原,乙型 /
- 中草药 /
- 聚类分析
Abstract: Objective To investigate the features of traditional Chinese medicine( TCM) and prescription rules in the treatment of HBeAg- positive chronic hepatitis B( CHB). Methods A systematic search was performed for the articles on the TCM diagnosis and treatment of HBeAg-positive CHB,the information of TCM diagnosis and treatment in medical records were extracted,and a database was established after data standardization. The Traditional Chinese Medicine Inheritance Support System was used to investigate the medication rule. Results A total of 100 articles with 135 medical records were included in this study. A total of 220 types of Chinese materia medica were used,among which Bupleurum chinense,Salvia miltiorrhiza,Radix Glycyrrhizae,Atractylodes macrocephala Koidz.,and Poria cocos were frequently used. As for the meridian entry of drugs,liver meridian,spleen meridian,and stomach meridian were commonly used. The analysis showed that the core drugs for HBeAg- positive CHB were Bupleurum chinense,Atractylodes macrocephala Koidz.,Radix Paeoniae Alba,Radix Curcumae,Salvia miltiorrhiza,Radix Glycyrrhizae,Poria cocos,Polygonum cuspidatum,Astragalus membranaceus,Herba Artemisiae Scopariae,and Hedyotis diffusa. A total of 20 core drug combinations were deduced based on complex system entropy clustering,and 10 new prescriptions were obtained using unsupervised entropy hierarchical clustering. Conclusion In this study,literature mining and inductive analysis show that the syndromes of stagnation of liver qi and spleen deficiency and liver and gallbladder damp- heat are common syndrome types of HBeAg- positive CHB. The medicine suits and prescriptions refined in this study can be used for reference in clinical practice.
- hepatitis B,chronic /
- hepatitis B core antigens /
- drugs,Chinese herbal /
- cluster analysis

HTML全文

参考文献(12)

[1]Specialized Committee on Internal Medicine and Hepatobiliary Diseases,China Association of Chinese Medicine,Liver Research Center,Beijing Union University School of Traditional Chinese Medicine.Preliminary views on"liver warm disease"as the name of viral hepatitis in traditional Chinese medicine[J].Beijing J Tradit Chin Med,1995,14(6):12-13.(in Chinese)中国中医药学会内科肝胆病专业委员会,北京联合大学中医药学院肝病研究中心.关于把病毒性肝炎的中医病名定为“肝温”的初步意见[J].北京中医,1995,14(6):12-13.

[2]Chinese Society of Hepatology,Chinese Society of Infectious Diseases,Chinese Medical Association.The guideline of prevention and treatment for chronic hepatitis B:a 2015 update[J].J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015年更新版)[J].临床肝胆病杂志,2015,31(12):1941-1960.

[3]LI XK,YE YA,DU HB.Challenges and opportunities met by TCM treatment for chronic hepatitis B:based on 2015 prevention and cure guidelines of the disease[J].World Chin Med,2016,11(2):364-367.(in Chinese)李小科,叶永安,杜宏波.基于2015年版慢性乙型肝炎防治指南谈中医药治疗的机遇与挑战[J].世界中医药,2016,11(2):364-367.

[4]YOU X,XIONG DG,GUO ZB,et al.Advancement of a variety of chemical constituents and pharmacological mechanisms of poria cocos[J].J Anhui Agric Sci,2015,43(2):106-109.(in Chinese)游昕,熊大国,郭志斌,等.茯苓多种化学成分及药理作用的研究进展[J].安徽农业科学,2015,43(2):106-109.

[5]DUAN HP.Experimental study on effect of CMP on the expression of hepatitis B virus in 2.2.15 cel line[D].Wuhan:Wuhan University,2004.(in Chinese)段会平.羧甲基茯苓多糖体外抗乙肝病毒作用的实验研究[D].武汉:武汉大学,2004.

[6]PU JY,HE L,WU SY,et al.Research advances in antiviral effect of triterpenes in Glycyrrhiza plants[J].Chin J Virol,2013,29(6):673-679.(in Chinese)蒲洁莹,何莉,吴思宇,等.甘草属植物中三萜类化合物的抗病毒作用研究进展[J].病毒学报,2013,29(6):673-679.

[7]YE YA,JIANG F,ZHAO ZM,et al.Chinese medical pattern distribution of chronic type hepatitis B[J].J Tradit Chin Med,2007,48(3):256-258.(in Chinese)叶永安,江峰,赵志敏,等.慢性乙型肝炎中医证型分布规律研究[J].中医杂志,2007,48(3):256-258.

[8]YIN YY,LIN YH,ZONG YL,et al.Study of Chaishao Liujunzi Decoction on immune mediated pathogenesis of liver stagnation and spleen deficiency type chronic hepatitis B[J].Liaoning J Tradit Chin Med,2014,41(11):2394-2396.(in Chinese)尹燕耀,林云华,宗亚力,等.柴芍六君子汤加减对肝郁脾虚型慢性乙型肝炎免疫介导发病机制的干预研究[J].辽宁中医杂志,2014,41(11):2394-2396.

[9]JING YF,WANG T,LAN BW.Clinical effect of Shugan Jianpi decoction combined with lamivudine in treatment of chronic hepatitis B[J].Chin J Clin Ration Drug Use,2012,5(4):56-57.(in Chinese)景永峰,王涛,兰保伟.疏肝健脾汤联合拉米夫定治疗慢性乙型肝炎临床观察[J].临床合理用药杂志,2012,5(4):56-57.

[10]YE YA,SHAO FZ,ZHOU DQ,et al.Clinical effect of traditional Chinese medicine combined with adefovir dipivoxil in treatment of chronic hepatitis B:a randomized controlled trial[C]//Colloguium proceedings on the 20nd annual meeting of tradition and western medicine on liver disease.Zhangjiajie:[s.n.],2011.(in Chinese)叶永安,邵凤珍,周大桥,等.中药联合阿德福韦酯治疗慢性乙型肝炎随机对照研究[C]//第二十次全国中西医结合肝病学术会议论文汇编.张家界:[出版者不详],2011.

[11]WEI PH,JIANG YP,DENG CY.Jiang Yiping's good experience in syndrome differentiation-based treatment of chronic hepatitis B[J].Jiangxi J Tradit Chin Med,2015,46(7):19-21.(in Chinese)魏鹏辉,江一平,邓陈英.江一平辨治慢性乙型肝炎经验撷菁[J].江西中医药,2015,46(7):19-21.

[12]YE YA,TIAN DL,JIANG J,et al.Study on common symptoms and distribution characteristics of traditional Chinese medicine syndromes of 1003 chronic hepatitis B(ALT≥2ULN)patients[J].World Chin Med,2015,10(9):1293-1298.(in Chinese)叶永安,田德禄,蒋健,等.1003例慢性乙型肝炎(ALT≥2×ULN)患者中医常见症状及证候分布特点研究[J].世界中医药,2015,10(9):1293-1298.

施引文献

资源附件(0)

访问统计